FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lauren Abrey

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Olivier L Chinot; Yannick Kerloëguen; David R Macdonald; Gudrun Zahlmann; Lauren E Abrey; Timothy F Cloughesy
Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.
Lauren Q Shapiro; Yoshiya Yamada; Zhigang Zhang; Fabio M Iwamoto; Sasan Karimi; Andrew B Lassman; Lauren E Abrey; Kathryn Beal; Anuj Goenka; Philip H Gutin
Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
Antonio M P Omuro; Katherine S Panageas; Anne S Reiner; Cynthia Salvant; Craig P Nolan; Lauren E Abrey; Timothy Chan; Lisa M Deangelis; Igor T Gavrilovic; Adriana Heguy; Adília Hormigo; Andreas F Hottinger; Jason Huse; Thomas J Kaley; Andrew Kaufman; mustafa khasraw; Andrew B Lassman; Ingo K Mellinghoff
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lauren Abrey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Olivier L Chinot; Yannick Kerloëguen; David R Macdonald; Gudrun Zahlmann; Lauren E Abrey; Timothy F Cloughesy
Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.
Current neurology and neuroscience reports 2013;13(5):347.
2013: Lauren Q Shapiro; Yoshiya Yamada; Zhigang Zhang; Fabio M Iwamoto; Sasan Karimi; Andrew B Lassman; Lauren E Abrey; Kathryn Beal; Anuj Goenka; Philip H Gutin
Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
International journal of radiation oncology, biology, physics 2013;85(3):636-42.
2013: Antonio M P Omuro; Katherine S Panageas; Anne S Reiner; Cynthia Salvant; Craig P Nolan; Lauren E Abrey; Timothy Chan; Lisa M Deangelis; Igor T Gavrilovic; Adriana Heguy; Adília Hormigo; Andreas F Hottinger; Jason Huse; Thomas J Kaley; Andrew Kaufman; mustafa khasraw; Andrew B Lassman; Ingo K Mellinghoff
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.
Neuro-oncology 2013;15(2):242-50.
2013: Jethro Hu; Nadia Salem; Jeffrey G Supko; Patrick Y Wen; Lauren E Abrey; Jan Drappatz; Camilo E Fadul; Fred Hochberg
A phase II trial of oral gimatecan for recurrent glioblastoma.
Journal of neuro-oncology 2013;111(3):347-53.
2013: Sasan Karimi; Sasan Partovi; Vineet Punia; Lauren E Abrey; Vaios Hatzoglou; Lisa M Deangelis
Post-treatment T1 shortening in primary CNS lymphoma.
Journal of neuro-oncology 2013;111(1):25-31.
2013: Lakshmi Nayak; Antonio M P Omuro; Michael Prados; David A Reardon; Patrick Y Wen; Lauren E Abrey; Lisa M Deangelis; Jan Drappatz; Mark R Gilbert
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
Leukemia & lymphoma 2013;54(1):58-61.
2012: Jacob G Scott; Joanna H Shih; John H Suh; Luc Taillandier; Michael A Vogelbaum; Sonia Zouaoui; Hélène Mathieu-Daudé; Lakshmi Nayak; David M Peereboom; Valérie Rigau; Lauren E Abrey; Luc Bauchet; Samuel T Chao; Anna R Cooper; Lisa M DeAngelis; Pascale Fabbro-Peray; Tyler J Fraum; Fabio M Iwamoto
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older.
Cancer 2012;118(22):5595-600.
2012: Whitney B Pope; Michael Prados; Vinay K Puduvalli; Xin Joe Qiao; Patricia Lada Rn; David Schiff; James Vredenburgh; Patrick Y Wen; Jing Wu; Xi Xue; Geoffrey S Young; Wai-Kwan A Yung; Benjamin M Ellingson; Jonathan Goldin; Rajan Jain; Hyun J Kim; Albert Lai; Tom Mikkelsen; Phioanh Nghiemphu; Nina Paleologos; Lauren E Abrey; Dawit Aregawi; Dan Barboriak; Soonmee Cha; Timothy F Cloughesy
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.
Journal of neuro-oncology 2012;108(3):491-8.
2012: Katherine S Panageas; Andreana L Rivera; H Ian Robins; Brandon G Rocque; Gloria B Roldán Urgoiti; Marc K Rosenblum; David Schiff; Susan A Weaver; Patrick Y Wen; Lauren E Abrey; Kenneth D Aldape; Lynn S Ashby; J Gregory Cairncross; Marc C Chamberlain; Timothy F Cloughesy; Lisa De Angelis; April F Eichler; Barbara J Fisher; Richard M Green; Fabio M Iwamoto; Suresh C Jhanwar; Francois G. Kamar; Keith L Ligon; David N Louis; Warren P Mason; Nina Paleologos; Andrew B Lassman
Initial treatment patterns over time for anaplastic oligodendroglial tumors.
Neuro-oncology 2012;14(6):761-7.
2012: Lauren E Abrey
The impact of chemotherapy on cognitive outcomes in adults with primary brain tumors.
Journal of neuro-oncology 2012;108(2):285-90.
2011: Fabio M Iwamoto; Maryam Jahdi; Sasan Karimi; Andrew B Lassman; Katherine S Panageas; Elyn Riedel; Lauren E Abrey; Jocelynn Dantis; Lisa M Deangelis; Martin Fleisher; Eric C Holland; Andreas F Hottinger; Adília Hormigo
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
Journal of neuro-oncology 2011;105(3):607-12.
2011: Phioanh Leia Nghiemphu; Michael D Prados; H Ian Robins; Alejandro Torres-Trejo; Patrick Y Wen; Lauren E Abrey; Susan M Chang; Timothy F Cloughesy; Lisa M DeAngelis; Alexis Demopoulos; Jan Drappatz; Howard A Fine; Karen Fink; Santosh Kesari; Kathleen R Lamborn; Andrew B Lassman; Frank S Lieberman; Mark G Malkin; Minesh Mehta
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.
International journal of radiation oncology, biology, physics 2011;81(5):1422-7.
2011: Fabio M Iwamoto; Maryam Jahdi; Sasan Karimi; Andrew B Lassman; Katherine S Panageas; Elyn Riedel; Lauren E Abrey; Jocelynn Dantis; Lisa M DeAngelis; Martin Fleisher; Eric C Holland; Andreas F Hottinger; Adília Hormigo
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas.
Neuro-oncology 2011;13(11):1244-51.
2011: Patrick G Morris; Lauren E Abrey; Lisa M Deangelis; Katherine S Panageas; Anne S Reiner; Brian S Seko; Nian Wu; Antonio Omuro
Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy.
Leukemia & lymphoma 2011;52(10):1891-7.
2011: Andreas F Hottinger; Fabio M Iwamoto; Sasan Karimi; Andrew B Lassman; Katherine S Panageas; Joseph Park; Elyn Riedel; Lauren E Abrey; Jocelynn Dantis; Lisa M DeAngelis; Martin Fleisher; Eric C Holland; Adília Hormigo
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
Annals of neurology 2011;70(1):163-9.
2011: Andrew B Lassman; Fabio M Iwamoto; Timothy F Cloughesy; Kenneth D Aldape; Andreana L Rivera; April F Eichler; David N Louis; Nina Paleologos; Barbara J Fisher; Lynn S Ashby; J Gregory Cairncross; Gloria B Roldán; Patrick Y Wen; Keith L Ligon; David Schiff; H Ian Robins; Brandon G Rocque; Marc C Chamberlain; Warren P Mason; Susan A Weaver; Richard M Green; Francois G. Kamar; Lauren E Abrey; Lisa De Angelis; Suresh C Jhanwar; Marc K Rosenblum; Katherine S Panageas
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.
Neuro-oncology 2011;13(6):649-59.
2011: Jeffrey S Wefel; Timothy Cloughesy; James L Zazzali; Maoxia Zheng; Michael Prados; Patrick Y Wen; Tom Mikkelsen; David Schiff; Lauren E Abrey; W K Alfred Yung; Nina Paleologos; Martin K Nicholas; Randy Jensen; James Vredenburgh; Asha Das; Henry S Friedman
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.
Neuro-oncology 2011;13(6):660-8.
2011: Lauren E Abrey
Advances in primary CNS lymphoma: randomized clinical trials of chemotherapy and whole-brain radiotherapy.
Current neurology and neuroscience reports 2011;11(3):243-5.
2011: Ase M Ballangrud; Kathryn Beal; Cameron Brennan; Philip H Gutin; Wei Huang; Fabio M Iwamoto; Sasan Karimi; Stella Lymberis; Sunitha Thakur; Lauren E Abrey; Jenghwa Chang
Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent glioma.
Medical physics 2011;38(5):2724-30.
2011: Lakshmi Nayak; Cyrus V Hedvat; Marc K Rosenblum; Lauren E Abrey; Lisa De Angelis
Late relapse in primary central nervous system lymphoma: clonal persistence.
Neuro-oncology 2011;13(5):525-9.
2011: Oussama Abla; Sheila Weitzman; Jean-Yves Blay; Brian Patrick O'Neill; Lauren E Abrey; Edward Neuwelt; Nancy D Doolittle; Joachim Baehring; Kamnesh Pradhan; S Eric Martin; Michael Guerrera; Shafqat Shah; Hervé Ghesquieres; Michael Silver; Rebecca A Betensky; Tracy Batchelor
Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(2):346-52.
2011: Kathryn Beal; Lauren E Abrey; Philip H Gutin
Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.
Radiation oncology (London, England) 2011;6():2.
2011: Michael Prados; Timothy F Cloughesy; Meghna Samant; Liang Fang; Patrick Y Wen; Tom Mikkelsen; David Schiff; Lauren E Abrey; W K Alfred Yung; Nina Paleologos; M Kelly Nicholas; Randy Jensen; James Vredenburgh; Asha Das; Henry S Friedman
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab.
Neuro-oncology 2011;13(1):143-51.
2010: Douglas Ney; Anne S Reiner; Katherine S Panageas; Hayley S Brown; Lisa De Angelis; Lauren E Abrey
Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
Cancer 2010;116(19):4605-12.
2010: Patrick G Morris; Lauren E Abrey
Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas.
Targeted oncology 2010;5(3):193-200.
2010: Fabio M Iwamoto; Kathleen R Lamborn; H Ian Robins; Minesh Mehta; Susan M Chang; Nicholas A Butowski; Lisa De Angelis; Lauren E Abrey; Wei-Ting Zhang; Michael D Prados; Howard A Fine
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).
Neuro-oncology 2010;12(8):855-61.
2010: Lauren E Abrey
Hematology. Individualized methotrexate dosing in primary CNS lymphoma.
Nature reviews. Clinical oncology 2010;7(6):306-7.
2010: James J Vredenburgh; Timothy F Cloughesy; Meghna Samant; Michael Prados; Patrick Y Wen; Tom Mikkelsen; David Schiff; Lauren E Abrey; W K Alfred Yung; Nina Paleologos; Martin K Nicholas; Randy Jensen; Asha Das; Henry S Friedman
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study.
The oncologist 2010;15(12):1329-34.
2010: Lauren E Abrey; Fabio M Iwamoto; Thomas Finnegan
Clinical monograph: Clinical considerations for older patients with glioblastoma.
Clinical advances in hematology & oncology : H&O 2010;8(1 Suppl 1):1-14; quiz 15-6.
2010: Jeffrey J Raizer; Lauren E Abrey; Andrew B Lassman; Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Kenneth A Aldape; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank Lieberman; Timothy F Cloughesy; H Ian Robins; Janet Dancey; Michael D Prados
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.
Neuro-oncology 2010;12(1):95-103.
2010: Jeffrey J Raizer; Lauren E Abrey; Andrew B Lassman; Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Kenneth Aldape; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank Lieberman; Timothy F Cloughesy; H Ian Robins; Janet Dancey; Michael D Prados
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas.
Neuro-oncology 2010;12(1):87-94.
2010: Andrew D Norden; Jeffrey J Raizer; Lauren E Abrey; Kathleen R Lamborn; Andrew B Lassman; Susan M Chang; W K Alfred Yung; Mark R Gilbert; Howard A Fine; Minesh Mehta; Lisa De Angelis; Timothy F Cloughesy; H Ian Robins; Kenneth Aldape; Janet Dancey; Michael D Prados; Frank Lieberman; Patrick Y Wen
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Journal of neuro-oncology 2010;96(2):211-7.
2009: Trudy N Small; Andrew D Zelenetz; Ariela Noy; Robert D. Rice; Tanya M Trippett; Lauren E Abrey; Carol S Portlock; Emily J McCullagh; Jill M Vanak; Ann Marie Mulligan; Craig Moskowitz
Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1538-42.
2009: Lauren E Abrey
Primary central nervous system lymphoma.
Current opinion in neurology 2009;22(6):675-80.
2009: Fabio M Iwamoto; Anne S Reiner; Lakshmi Nayak; Katherine S Panageas; Elena B Elkin; Lauren E Abrey
Prognosis and patterns of care in elderly patients with glioma.
Cancer 2009;115(23):5534-40.
2009: Andreas F Hottinger; Hannah Yoon; Lisa De Angelis; Lauren E Abrey
Neurological outcome of long-term glioblastoma survivors.
Journal of neuro-oncology 2009;95(3):301-5.
2009: Patrick Y Wen; W K Alfred Yung; Kathleen R Lamborn; Andrew D Norden; Timothy F Cloughesy; Lauren E Abrey; Howard A Fine; Susan M Chang; H Ian Robins; Karen Fink; Lisa De Angelis; Minesh Mehta; Emmanuelle di Tomaso; Jan Drappatz; Santosh kesari; Keith L Ligon; Ken Aldape; Rakesh K Jain; Charles D Stiles; Merrill J Egorin; Michael D Prados
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Neuro-oncology 2009;11(6):853-60.
2009: Fabio M Iwamoto; Lauren E Abrey; Kathryn Beal; Philip H Gutin; Marc K Rosenblum; Victor E Reuter; Lisa De Angelis; Andrew B Lassman
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.
Neurology 2009;73(15):1200-6.
2009: Henry S Friedman; Michael D Prados; Patrick Y Wen; Tom Mikkelsen; David Schiff; Lauren E Abrey; W K Alfred Yung; Nina Paleologos; Martin K Nicholas; Randy Jensen; James J Vredenburgh; Jane Huang; Maoxia Zheng; Timothy F Cloughesy
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4733-40.
2009: Douglas Ney; Lauren E Abrey
Maintenance therapy for central nervous system lymphoma with rituximab.
Leukemia & lymphoma 2009;50(9):1548-51.
2009: Philip H Gutin; Fabio M Iwamoto; Kathryn Beal; Nimish A Mohile; Sasan Karimi; Bob L Hou; Stella Lymberis; Yoshiya Yamada; Jenghwa Chang; Lauren E Abrey
Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
International journal of radiation oncology, biology, physics 2009;75(1):156-63.
2009: Fabio M Iwamoto; Anna R Cooper; Anne S Reiner; Lakshmi Nayak; Lauren E Abrey
Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).
Cancer 2009;115(16):3758-66.
2009: Jennifer L Clarke; Fabio M Iwamoto; Joohee Sul; Katherine S Panageas; Andrew B Lassman; Lisa De Angelis; Adília Hormigo; Craig P Nolan; Igor T Gavrilovic; Sasan Karimi; Lauren E Abrey
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3861-7.
2009: Tulika Ranjan; Lauren E Abrey
Current management of metastatic brain disease.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2009;6(3):598-603.
2009: Patrick G Morris; Lauren E Abrey
Therapeutic challenges in primary CNS lymphoma.
Lancet neurology 2009;8(6):581-92.
2009: Jose S Pulido; Robert A Vierkant; Janet E Olson; Lauren E Abrey; David Schiff; Brian Patrick O'Neill
Racial differences in primary central nervous system lymphoma incidence and survival rates.
Neuro-oncology 2009;11(3):318-22.
2009: Jeffrey P Greenfield; David K Jin; Lauren M Young; Paul J Christos; Lauren E Abrey; Shahin Rafii; Philip H Gutin
Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
Neurosurgery 2009;64(5):819-26; discussion 826-7.
2009: Lauren E Abrey
Gross total resection of low-grade glioma in adults.
Current neurology and neuroscience reports 2009;9(3):181-2.
2009: Lakshmi Nayak; Lauren E Abrey; Fabio M Iwamoto
Intracranial dural metastases.
Cancer 2009;115(9):1947-53.
2009: Teri N Kreisl; Andrew B Lassman; Paul Mischel; Neal Rosen; Howard I Scher; Julie T Feldstein; David Shaffer; Eric Lis; Lauren E Abrey
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).
Journal of neuro-oncology 2009;92(1):99-105.
2009: Denise D Correa; Mary Rocco-Donovan; Lisa De Angelis; Rima Dolgoff-Kaspar; Fabio M Iwamoto; Joachim Yahalom; Lauren E Abrey
Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy.
Journal of neuro-oncology 2009;91(3):315-21.
2009: Nicholas Butowski; Kathleen R Lamborn; Bee L Lee; Michael D Prados; Timothy F Cloughesy; Lisa De Angelis; Lauren E Abrey; Karen Fink; Frank S Lieberman; Minesh Mehta; H Ian Robins; Larry Junck; Andres M Salazar; Susan M Chang
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.
Journal of neuro-oncology 2009;91(2):183-9.
2009: Nicholas Butowski; Susan M Chang; Larry Junck; Lisa De Angelis; Lauren E Abrey; Karen Fink; Timothy F Cloughesy; Kathleen R Lamborn; Andres M Salazar; Michael D Prados
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).
Journal of neuro-oncology 2009;91(2):175-82.
2008: Fabio M Iwamoto; Anne S Reiner; Katherine S Panageas; Elena B Elkin; Lauren E Abrey
Patterns of care in elderly glioblastoma patients.
Annals of neurology 2008;64(6):628-34.
2008: Elena Bazzoli; Fabio M Iwamoto; Andrew D Zelenetz; Lisa De Angelis; Lauren E Abrey
Synchronous presentation of systemic and brain non-Hodgkin lymphoma.
Leukemia & lymphoma 2008;49(12):2370-3.
2008: Nimish A Mohile; Lisa De Angelis; Lauren E Abrey
Utility of brain FDG-PET in primary CNS lymphoma.
Clinical advances in hematology & oncology : H&O 2008;6(11):818-20, 840.
2008: S A Grimm; C A McCannel; Antonio M P Omuro; Andrés J M Ferreri; J-Y Blay; Edward A Neuwelt; Tali Siegal; Tracy T Batchelor; Kristoph Jahnke; Tamara N Shenkier; A J Hall; Francesc Graus; Ulrich Herrlinger; David Schiff; Jeffrey J Raizer; J Rubenstein; Normand Laperriere; Eckhard Thiel; Nancy D Doolittle; Fabio M Iwamoto; Lauren E Abrey
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
Neurology 2008;71(17):1355-60.
2008: Teri N Kreisl; Katherine S Panageas; Elena B Elkin; Lisa De Angelis; Lauren E Abrey
Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma.
Leukemia & lymphoma 2008;49(9):1710-6.
2008: Meltem Ekenel; Fabio M Iwamoto; Leah Ben-Porat; Katherine S Panageas; Joachim Yahalom; Lisa De Angelis; Lauren E Abrey
Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
Cancer 2008;113(5):1025-31.
2008: Elizabeth R Gerstner; Lauren E Abrey; David Schiff; Andrés J M Ferreri; Andrew Lister; Silvia Montoto; Richard Tsang; Eckhard Thiel; Francesc Graus; Dirk Behringer; Gerald Illerhaus; Susan Weaver; Patrick Wen; Alfredo Voloschin; Nancy Lee Harris; Tracy T Batchelor
CNS Hodgkin lymphoma.
Blood 2008;112(5):1658-61.
2008: Nimish A Mohile; Peter A Forsyth; Douglas Stewart; Jeffrey J Raizer; Nina Paleologos; Tarun Kewalramani; David N Louis; J Gregory Cairncross; Lauren E Abrey
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.
Journal of neuro-oncology 2008;89(2):187-93.
2008: Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank S Lieberman; Timothy F Cloughesy; H Ian Robins; Lauren E Abrey; Michael D Prados
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
Neuro-oncology 2008;10(4):631-42.
2008: Lauren E Abrey
Bevacizumab in recurrent malignant glioma.
Current neurology and neuroscience reports 2008;8(3):233-4.
2008: Kathleen R Lamborn; W K Alfred Yung; Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Lisa De Angelis; H Ian Robins; Frank S Lieberman; Howard A Fine; Karen L Fink; Larry Junck; Lauren E Abrey; Mark R Gilbert; Minesh Mehta; John Kuhn; Kenneth Aldape; Janelle Hibberts; Pamela M Peterson; Michael D Prados
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
Neuro-oncology 2008;10(2):162-70.
2008: Nimish A Mohile; Lisa De Angelis; Lauren E Abrey
The utility of body FDG PET in staging primary central nervous system lymphoma.
Neuro-oncology 2008;10(2):223-8.
2008: J E Safdieh; P A Mead; Kent A Sepkowitz; T E Kiehn; Lauren E Abrey
Bacterial and fungal meningitis in patients with cancer.
Neurology 2008;70(12):943-7.
2008: Sofia Haque; Meng Law; Lauren E Abrey; Robert J Young
Imaging of lymphoma of the central nervous system, spine, and orbit.
Radiologic clinics of North America 2008;46(2):339-61, ix.
2008: Fabio M Iwamoto; Antonio M P Omuro; Jeffrey J Raizer; Craig P Nolan; Adília Hormigo; Andrew B Lassman; Igor T Gavrilovic; Lauren E Abrey
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.
Journal of neuro-oncology 2008;87(1):85-90.
2008: Nancy D Doolittle; Lauren E Abrey; Tamara N Shenkier; Siegal Tali; Jacoline E C Bromberg; Edward A Neuwelt; Carole Soussain; Kristoph Jahnke; Patrick Johnston; Gerald Illerhaus; David Schiff; Tracy Batchelor; Silvia Montoto; Dale F Kraemer; Emanuele Zucca
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report.
Blood 2008;111(3):1085-93.
2008: Denise D Correa; Weiji Shi; Howard T Thaler; Angeles M Cheung; Lisa De Angelis; Lauren E Abrey
Longitudinal cognitive follow-up in low grade gliomas.
Journal of neuro-oncology 2008;86(3):321-7.
2008: Edward A Neuwelt; N Joan Abbott; Lauren E Abrey; William A Banks; Brian W Blakley; Thomas Davis; Britta Engelhardt; Paula Grammas; Maiken Nedergaard; John G Nutt; William Pardridge; Gary A Rosenberg; Quentin R Smith; Lester Drewes
Strategies to advance translational research into brain barriers.
Lancet neurology 2008;7(1):84-96.
2008: Oren Levy; Lisa De Angelis; Daniel A Filippa; Katherine S Panageas; Lauren E Abrey
Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.
Cancer 2008;112(1):151-6.
2007: Fabio M Iwamoto; Jazmin Schwartz; Neeta Pandit-Taskar; Scott Peak; Chaitanya R Divgi; Andrew D Zelenetz; John L Humm; Lauren E Abrey
Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma.
Cancer 2007;110(11):2528-34.
2007: Nimish A Mohile; Lauren E Abrey
Primary central nervous system lymphoma.
Neurologic clinics 2007;25(4):1193-207, xi.
2007: S A Grimm; J S Pulido; Kristoph Jahnke; David Schiff; A J Hall; Tamara N Shenkier; Tali Siegal; Nancy D Doolittle; Tracy T Batchelor; Ulrich Herrlinger; Edward A Neuwelt; Normand Laperriere; M C Chamberlain; J Y Blay; Andrés J M Ferreri; Antonio M P Omuro; Eckhard Thiel; Lauren E Abrey
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1851-5.
2007: Meltem Ekenel; Adília Hormigo; Scott Peak; Lisa De Angelis; Lauren E Abrey
Capecitabine therapy of central nervous system metastases from breast cancer.
Journal of neuro-oncology 2007;85(2):223-7.
2007: Gaurav D Shah; Joel S Silver; Steven Rosenfeld; Igor T Gavrilovic; Lauren E Abrey; Andrew B Lassman
Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.
Journal of neuro-oncology 2007;85(2):217-22.
2007: Gaurav D Shah; Joachim Yahalom; Denise D Correa; Rose K Lai; Jeffrey J Raizer; David Schiff; Renato LaRocca; Barbara Grant; Lisa De Angelis; Lauren E Abrey
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4730-5.
2007: Katherine S Panageas; Elena B Elkin; Leah Ben-Porat; Lisa De Angelis; Lauren E Abrey
Patterns of treatment in older adults with primary central nervous system lymphoma.
Cancer 2007;110(6):1338-44.
2007: Andreas F Hottinger; Lisa De Angelis; Joachim Yahalom; Lauren E Abrey
Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.
Neurology 2007;69(11):1178-82.
2007: Kristoph Jahnke; Eckhard Thiel; Lauren E Abrey; Edward A Neuwelt; Agnieszka Korfel
Diagnosis and management of primary intraocular lymphoma: an update.
Clinical ophthalmology (Auckland, N.Z.) 2007;1(3):247-58.
2007: Nimish A Mohile; Lauren E Abrey
Primary central nervous system lymphoma.
Seminars in radiation oncology 2007;17(3):223-9.
2007: Lauren E Abrey; David N Louis; Nina Paleologos; Andrew B Lassman; Jeffrey J Raizer; Warren Mason; Jonathan Lester Finlay; David R Macdonald; Lisa De Angelis; J Gregory Cairncross
Survey of treatment recommendations for anaplastic oligodendroglioma.
Neuro-oncology 2007;9(3):314-8.
2007: Denise D Correa; Leeza M Maron; Helena Harder; Martin Klein; C L Armstrong; P Calabrese; J E C Bromberg; Lauren E Abrey; Tracy T Batchelor; David Schiff
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1145-51.
2007: Jean-Pierre Armand; Vincent Ribrag; Jean-Luc Harrousseau; Lauren E Abrey
Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors.
Therapeutics and clinical risk management 2007;3(2):213-24.
2007: Teri D Nguyen; Lauren E Abrey
Intracranial hemorrhage in patients treated with bevacizumab and low-molecular weight heparin.
Clinical advances in hematology & oncology : H&O 2007;5(5):375-6; discussion 377-9.
2007: Lauren E Abrey
Anaplastic oligodendroglioma.
Current neurology and neuroscience reports 2007;7(3):189-90.
2007: James L Rubenstein; Jane Fridlyand; Lauren E Abrey; Arthur Shen; Jon Karch; Endi Wang; Samar Issa; Lloyd Damon; Michael Prados; Michael McDermott; Joan O'Brien; Christopher Haqq; Marc Shuman
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1350-6.
2007: Teri D Nguyen; Lauren E Abrey
Brain metastases: old problem, new strategies.
Hematology/oncology clinics of North America 2007;21(2):369-88.
2007: Andrew B Lassman; Lauren E Abrey
Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?
Nature clinical practice. Oncology 2007;4(2):78-9.
2007: Morris D Groves; Vinay K Puduvalli; Susan M Chang; Charles A Conrad; Mark R Gilbert; Ivo W Tremont-Lukats; Ta-Jen Liu; Pamela Peterson; David Schiff; Timothy F Cloughesy; Patrick Y Wen; Harry S Greenberg; Lauren E Abrey; Lisa De Angelis; Kenneth R Hess; Kathleen R Lamborn; Michael D Prados; W K Alfred Yung
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
Journal of neuro-oncology 2007;81(3):271-7.
2007: Gaurav D Shah; Lauren E Abrey
Chemotherapy for brain metastases: breast, gynecologic and non-melanoma skin malignancies.
Cancer treatment and research 2007;136():185-97.
2007: Denise D Correa; Lisa De Angelis; Weiji Shi; Howard T Thaler; Michael Lin; Lauren E Abrey
Cognitive functions in low-grade gliomas: disease and treatment effects.
Journal of neuro-oncology 2007;81(2):175-84.
2006: Lauren E Abrey; Leah Ben-Porat; Katherine S Panageas; Joachim Yahalom; Brian A Berkey; Walter Curran; Christopher Schultz; Steven Leibel; Diana Nelson; Minesh Mehta; Lisa De Angelis
Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5711-5.
2006: Sean A Grimm; Joachim Yahalom; Lauren E Abrey; Lisa De Angelis
Retinopathy in survivors of primary central nervous system lymphoma.
Neurology 2006;67(11):2060-2.
2006: Lauren E Abrey; Katherine S Panageas
Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community.
Leukemia & lymphoma 2006;47(12):2449-52.
2006: Scott Peak; Lauren E Abrey
Chemotherapy and the treatment of brain metastases.
Hematology/oncology clinics of North America 2006;20(6):1287-95.
2006: Igor T Gavrilovic; Adília Hormigo; Joachim Yahalom; Lisa De Angelis; Lauren E Abrey
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4570-4.
2006: Patrick Y Wen; W K Alfred Yung; Kathleen R Lamborn; Patricia Dahia; Yanfeng Wang; Bin Peng; Lauren E Abrey; Jeffrey Raizer; Timothy F Cloughesy; Karen Fink; Mark Gilbert; Susan Chang; Larry Junck; David Schiff; Frank Lieberman; Howard A Fine; Minesh Mehta; H Ian Robins; Lisa De Angelis; Morris D Groves; Vinay K Puduvalli; Victor Levin; Charles Conrad; Elizabeth A Maher; Kenneth Aldape; Michael Hayes; Laurie Letvak; Merrill J Egorin; Renaud Capdeville; Richard S. Kaplan; Anthony J Murgo; Charles D Stiles; Michael D Prados
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4899-907.
2006: Timothy F Cloughesy; Patrick Y Wen; H Ian Robins; Susan M Chang; Morris D Groves; Karen L Fink; Larry Junck; David Schiff; Lauren E Abrey; Mark R Gilbert; Frank S Lieberman; John Kuhn; Lisa De Angelis; Minesh Mehta; Jeffrey J Raizer; W K Alfred Yung; Kenneth Aldape; John Wright; Kathleen R Lamborn; Michael D Prados
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3651-6.
2006: Antonio M P Omuro; Jeffrey J Raizer; Alexis Demopoulos; Mark G Malkin; Lauren E Abrey
Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.
Journal of neuro-oncology 2006;78(3):277-80.
2006: Andrew B Lassman; Lauren E Abrey; Gaurav D Shah; Gaurav G Shah; Katherine S Panageas; Martin Begemann; Mark G Malkin; Jeffrey J Raizer
Systemic high-dose intravenous methotrexate for central nervous system metastases.
Journal of neuro-oncology 2006;78(3):255-60.
2006: Fabio M Iwamoto; Lisa De Angelis; Lauren E Abrey
Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients.
Neurology 2006;66(11):1763-5.
2006: Lauren E Abrey
Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?
Nature clinical practice. Neurology 2006;2(6):302-3.
2006: Andrew B Lassman; Lauren E Abrey
Unraveling molecular markers of biologic therapies in glioma.
Current neurology and neuroscience reports 2006;6(3):185-6.
2006: Kristoph Jahnke; Agnieszka Korfel; Brian Patrick O'Neill; Jean-Yves Blay; Lauren E Abrey; Peter Martus; Philip Poortmans; Tamara N Shenkier; Tracy T Batchelor; Edward A Neuwelt; Jeffrey J Raizer; David Schiff; Hendrik Pels; Ulrich Herrlinger; Harald Stein; Eckhard Thiel
International study on low-grade primary central nervous system lymphoma.
Annals of neurology 2006;59(5):755-62.
2006: Lauren E Abrey; Barrett H Childs; Nina Paleologos; Lynne Kaminer; Steven Rosenfeld; Donna Salzman; Jonathan Lester Finlay; Sharon L Gardner; Kendra Peterson; Wendy Hu; Lode Swinnen; Robert Bayer; Peter A Forsyth; Douglas Stewart; Anne M Smith; David R Macdonald; Susan Weaver; David A Ramsay; Stephen D Nimer; Lisa De Angelis; J Gregory Cairncross
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
Neuro-oncology 2006;8(2):183-8.
2006: Andrew B Lassman; Lauren E Abrey; Mark R Gilbert
Response of glioblastomas to EGFR kinase inhibitors.
The New England journal of medicine 2006;354(5):525-6; author reply 525-6.
2006: Fabio M Iwamoto; Lauren E Abrey
Primary dural lymphomas: a review.
Neurosurgical focus 2006;21(5):E5.
2006: Antonio M P Omuro; Lauren E Abrey
Chemotherapy for primary central nervous system lymphoma.
Neurosurgical focus 2006;21(5):E12.
2005: Enrico Franceschi; Antonio M P Omuro; Andrew B Lassman; Alexis Demopoulos; Craig Nolan; Lauren E Abrey
Salvage temozolomide for prior temozolomide responders.
Cancer 2005;104(11):2473-6.
2005: Katherine S Panageas; Elena B Elkin; Lisa De Angelis; Leah Ben-Porat; Lauren E Abrey
Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Cancer 2005;104(11):2466-72.
2005: Andrew B Lassman; Michael R Rossi; Jeffrey J Raizer; Jeffrey R Razier; Lauren E Abrey; Frank S Lieberman; Chelsea N Grefe; Kathleen R Lamborn; William Pao; Alan H Shih; John Kuhn; Richard Wilson; Norma J Nowak; John Kenneth Cowell; Lisa De Angelis; Patrick Y Wen; Mark R Gilbert; Susan Chang; W A Yung; Michael Prados; Eric C Holland
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7841-50.
2005: Antonio M P Omuro; Leah Ben-Porat; Katherine S Panageas; Amy K Kim; Denise D Correa; Joachim Yahalom; Lisa De Angelis; Lauren E Abrey
Delayed neurotoxicity in primary central nervous system lymphoma.
Archives of neurology 2005;62(10):1595-600.
2005: Marc C Chamberlain; Craig Nolan; Lauren E Abrey
Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.
Journal of neuro-oncology 2005;75(1):71-83.
2005: Timothy F Cloughesy; John Kuhn; H Ian Robins; Lauren E Abrey; Patrick Y Wen; Karen Fink; Frank S Lieberman; Minesh Mehta; Susan Chang; Alfred Yung; Lisa De Angelis; David Schiff; Larry Junck; Morris Groves; Steve Paquette; John Wright; Kathleen R Lamborn; Said M Sebti; Michael Prados
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6647-56.
2005: Lauren E Abrey; Denise D Correa
Treatment-related neurotoxicity.
Hematology/oncology clinics of North America 2005;19(4):729-38, viii.
2005: Lauren E Abrey; Tracy T Batchelor; Andrés J M Ferreri; Mary Gospodarowicz; Elisa J Pulczynski; Emanuele Zucca; Justine R Smith; Agnieszka Korfel; Carole Soussain; Lisa De Angelis; Edward A Neuwelt; Brian Patrick O'Neill; Eckhard Thiel; Tamara N Shenkier; Francesc Graus; Martin J van den Bent; John F Seymour; Philip Poortmans; James O Armitage; Franco Cavalli
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5034-43.
2005: Lauren E Abrey
Controversies in primary CNS lymphoma.
Expert review of neurotherapeutics 2005;5(4):459-64.
2005: Antonio M P Omuro; Mark G Kris; Vincent A Miller; Enrico Franceschi; Neelam Shah; Daniel T Milton; Lauren E Abrey
High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
Cancer 2005;103(11):2344-8.
2005: Lauren E Abrey
Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
Current neurology and neuroscience reports 2005;5(3):167-8.
2005: Tamara N Shenkier; Jean-Yves Blay; Brian Patrick O'Neill; Philip Poortmans; Eckhard Thiel; Kristoph Jahnke; Lauren E Abrey; Edward A Neuwelt; Richard Tsang; Tracy T Batchelor; Nancy Harris; Andrés J M Ferreri; Maurilio Ponzoni; Peter O'Brien; James Rubenstein; Joseph Michael Connors
Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2233-9.
2005: Denise D Correa; Lauren E Abrey
Imaging neurotoxicity: is a picture worth a thousand words?
AJNR. American journal of neuroradiology 2005;26(2):205-6.
2005: Nancy D Doolittle; Lauren E Abrey; Archie Bleyer; Steven Brem; Thomas P Davis; Paula Dore-Duffy; Lester Drewes; Walter A Hall; John M Hoffman; Agnieszka Korfel; Robert L Martuza; Leslie L Muldoon; David M Peereboom; Darryl R Peterson; samuel rabkin; Quentin R Smith; Glen H J Stevens; Edward A Neuwelt
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):421-8.
2005: Antonio M P Omuro; Lisa De Angelis; Joachim Yahalom; Lauren E Abrey
Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
Neurology 2005;64(1):69-74.
2005: Craig P Nolan; Lauren E Abrey
Leptomeningeal metastases from leukemias and lymphomas.
Cancer treatment and research 2005;125():53-69.
2005: Jeffrey J Raizer; Jason A Koutcher; Lauren E Abrey; Katherine S Panageas; Lisa De Angelis; Eric Lis; S Xu; Kristen L Zakian
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Journal of neuro-oncology 2005;71(2):173-80.
2005: Igor T Gavrilovic; Lauren E Abrey
Diagnosis and treatment of primary central nervous system lymphoma.
Current oncology reports 2005;7(1):47-54.
2004: Roelien H Enting; Alexis Demopoulos; Lisa De Angelis; Lauren E Abrey
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
Neurology 2004;63(5):901-3.
2004: Igor T Gavrilovic; Lauren E Abrey
Primary central nervous system lymphoma.
Current oncology reports 2004;6(5):388-95.
2004: Rose Lai; Chau Dang; Mark G Malkin; Lauren E Abrey
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma.
Cancer 2004;101(4):810-6.
2004: Francois G. Kamar; Lauren E Abrey
Management of primary central nervous system lymphoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2004;2(4):341-9.
2004: Jeffrey J Raizer; Mark G Malkin; Martin Kleber; Lauren E Abrey
Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
Neuro-oncology 2004;6(3):247-52.
2004: Adília Hormigo; Lauren E Abrey; Murk-Hein Heinemann; Lisa De Angelis
Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
British journal of haematology 2004;126(2):202-8.
2004: Antonio M P Omuro; Lauren E Abrey
Brain metastases.
Current neurology and neuroscience reports 2004;4(3):205-10.
2004: Denise D Correa; Lisa De Angelis; Weiji Shi; Howard T Thaler; A Glass; Lauren E Abrey
Cognitive functions in survivors of primary central nervous system lymphoma.
Neurology 2004;62(4):548-55.
2004: Rose Lai; Lauren E Abrey; Marc K Rosenblum; Lisa De Angelis
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
Neurology 2004;62(3):451-6.
2004: Lauren E Abrey
Advancing the treatment of malignant glioma: act local, think global.
Cancer investigation 2004;22(1):169.
2003: Lauren E Abrey; Craig Moskowitz; Warren P Mason; Michael Crump; Douglas Stewart; Peter A Forsyth; Nina Paleologos; Denise D Correa; Nicole D Anderson; Dawn Caron; Andrew D Zelenetz; Stephen D Nimer; Lisa De Angelis
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4151-6.
2003: Lauren E Abrey; Barrett H Childs; Nina Paleologos; Lynne Kaminer; Steven Rosenfeld; Donna Salzman; Jonathan Lester Finlay; Sharon L Gardner; Kendra Peterson; Wendy Hu; Lode Swinnen; Robert Bayer; Peter A Forsyth; Douglas Stewart; Anne M Smith; David R Macdonald; Susan Weaver; David A Ramsey; Stephen D Nimer; Lisa De Angelis; J Gregory Cairncross
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.
Journal of neuro-oncology 2003;65(2):127-34.
2003: Enrico C Lallana; Lauren E Abrey
Update on the therapeutic approaches to brain tumors.
Expert review of anticancer therapy 2003;3(5):655-70.
2003: Denise D Correa; Nicole D Anderson; Aviva Glass; Warren P Mason; Lisa De Angelis; Lauren E Abrey
Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.
Clinical advances in hematology & oncology : H&O 2003;1(8):490.
2003: Andrés J M Ferreri; Lauren E Abrey; Jean-Yves Blay; Bettina Borisch; Jacob Hochman; Edward A Neuwelt; Joachim Yahalom; Emanuele Zucca; Franco Cavalli; James Armitage; Tracy Batchelor
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2407-14.
2003: Lauren E Abrey; Minesh Mehta
Treatment of brain metastases: a short review of current therapies and the emerging role of temozolomide.
Clinical advances in hematology & oncology : H&O 2003;1(4):231-6.
2002: Warren P Mason; Fred Gentili; David R Macdonald; Subramanian Hariharan; Charlene R Cruz; Lauren E Abrey
Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Journal of neurosurgery 2002;97(2):341-6.
2002: Fernando C Maluf; Lisa De Angelis; Jeffrey J Raizer; Lauren E Abrey
High-grade gliomas in patients with prior systemic malignancies.
Cancer 2002;94(12):3219-24.
2002: Raja B Khan; Weiji Shi; Howard T Thaler; Lisa De Angelis; Lauren E Abrey
Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?
Journal of neuro-oncology 2002;58(2):175-8.
2002: Nancy D Doolittle; Lauren E Abrey; Nicolay Ferrari; Walter A Hall; Edward R Laws; Roger E McLendon; Leslie L Muldoon; David M Peereboom; Darryl R Peterson; Charles Patrick Reynolds; Peter D Senter; Edward A Neuwelt
Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1702-9.
2002: Andrew Lister; Lauren E Abrey; John T Sandlund
Central nervous system lymphoma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():283-96.
2002: Raja B Khan; Jeffrey J Raizer; Mark G Malkin; Kimberley A Bazylewicz; Lauren E Abrey
A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
Neuro-oncology 2002;4(1):39-43.
2002: Deric Minwoo Park; Lauren E Abrey
Pharmacotherapy of primary CNS lymphoma.
Expert opinion on pharmacotherapy 2002;3(1):39-49.
2001: Lauren E Abrey; C Christodoulou
Temozolomide for treating brain metastases.
Seminars in oncology 2001;28(4 Suppl 13):34-42.
2001: Lauren E Abrey; J D Olson; Jeffrey J Raizer; M Mack; A Rodavitch; D Y Boutros; Mark G Malkin
A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.
Journal of neuro-oncology 2001;53(3):259-65.
2000: Lauren E Abrey; Joachim Yahalom; Lisa De Angelis
Treatment for primary CNS lymphoma: the next step.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3144-50.
2000: Nuno Lobo Antunes; Yasmin Khakoo; Katherine K Matthay; Robert C Seeger; Daniel O Stram; Elizabeth Gerstner; Lauren E Abrey; Josep Dalmau
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.
Journal of pediatric hematology/oncology 2000;22(4):315-20.
1999: Patricio Ignacio Meneses; Lauren E Abrey; K A Hajjar; Sakir Humayun Gultekin; Robert M Duvoisin; K I Berns; Myrna R Rosenfeld
Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3689-94.
1999: Lauren E Abrey; Marc K Rosenblum; Esperanza B Papadopoulos; Barrett H Childs; Jonathan Lester Finlay
High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors.
Journal of neuro-oncology 1999;44(2):147-53.
1999: Deborah T Blumenthal; Jeffrey J Raizer; Marc K Rosenblum; Mark H Bilsky; S Hariharan; Lauren E Abrey
Primary intracranial neoplasms in patients with HIV.
Neurology 1999;52(8):1648-51.
1999: Lauren E Abrey; Josep Dalmau
Neurologic complications of ovarian carcinoma.
Cancer 1999;85(1):127-33.
1998: Lauren E Abrey; Marc K Rosenblum; Lisa De Angelis
Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy.
Journal of neuro-oncology 1998;39(3):261-5.
1998: Lauren E Abrey; Lisa De Angelis; Joachim Yahalom
Long-term survival in primary CNS lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):859-63.
1996: Lauren E Abrey; CH Waters
Basal ganglia calcification after mumps encephalitis.
Movement disorders : official journal of the Movement Disorder Society 1996;11(6):755-6.
1995: A L Rabinowicz; Lauren E Abrey; D R Hinton; W T Couldwell
Cerebral neurocytoma: an unusual cause of refractory epilepsy. Case report and review of the literature.
Epilepsia 1995;36(12):1237-40.
1995: Lauren E Abrey
Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy.
Neurology 1995;45(5):1019.